Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Breast Cancer Research and Treatment|February 9, 2012
The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish populationPatricia Rodrigues, Jessica Furriol, Eduardo Tormo, et al.
Clinical Breast Cancer|December 4, 2003
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancerAntonio Antón, Javier Hornedo, Ana Lluch, et al.
Plos One|January 24, 2013
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjectsBegoña Pineda, Miguel Ángel García-Pérez, Antonio Cano, et al.
International Journal of Molecular Sciences|February 28, 2013
Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patientsPatricia Rodrigues, Jessica Furriol, Begoña Bermejo, et al.
Anti-Cancer Drugs|October 9, 2013
Zoledronic acid in the treatment of metastatic breast cancerAna Lluch, Juan Cueva, Manuel Ruiz-Borrego, et al.
IUBMB Life|April 24, 2015
Involvement of Different networks in mammary gland involution after the pregnancy/lactation cycle: Implications in breast cancerRosa Zaragozá, Elena R García-Trevijano, Ana Lluch, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2018
Breast cancer in pregnant patients: A review of the literatureMaría Teresa Martínez, Begoña Bermejo, Cristina Hernando, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumorsAna Lluch, Isabel Alvarez, Montserrat Muñoz, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 24, 2015
In response: Genomic profile of breast cancerMiguel Angel Seguí, Carlos Crespo, Javier Cortés, et al.
Advances in Therapy|November 10, 2011
An overview of letrozole in postmenopausal women with hormone-responsive breast cancerAgustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Breast Cancer Research and Treatment|February 9, 2012
The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish populationPatricia Rodrigues, Jessica Furriol, Eduardo Tormo, et al.
Clinical Breast Cancer|December 4, 2003
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancerAntonio Antón, Javier Hornedo, Ana Lluch, et al.
Plos One|January 24, 2013
Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjectsBegoña Pineda, Miguel Ángel García-Pérez, Antonio Cano, et al.
International Journal of Molecular Sciences|February 28, 2013
Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patientsPatricia Rodrigues, Jessica Furriol, Begoña Bermejo, et al.
Anti-Cancer Drugs|October 9, 2013
Zoledronic acid in the treatment of metastatic breast cancerAna Lluch, Juan Cueva, Manuel Ruiz-Borrego, et al.
IUBMB Life|April 24, 2015
Involvement of Different networks in mammary gland involution after the pregnancy/lactation cycle: Implications in breast cancerRosa Zaragozá, Elena R García-Trevijano, Ana Lluch, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 6, 2018
Breast cancer in pregnant patients: A review of the literatureMaría Teresa Martínez, Begoña Bermejo, Cristina Hernando, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumorsAna Lluch, Isabel Alvarez, Montserrat Muñoz, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 24, 2015
In response: Genomic profile of breast cancerMiguel Angel Seguí, Carlos Crespo, Javier Cortés, et al.
Advances in Therapy|November 10, 2011
An overview of letrozole in postmenopausal women with hormone-responsive breast cancerAgustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, et al.
Pageof 19